About OMNILife Sciences
OMNILife Sciences is a company based in Taunton (United States) founded in 1999 was acquired by Corin in March 2019. OMNILife Sciences has raised $33.37 million across 7 funding rounds from investors including JPMorgan Chase, Corin Group and Deerfield. OMNILife Sciences offers products and services including ApolloKnee™, Apollo™ Robot, and BalanceBot™. OMNILife Sciences operates in a competitive market with competitors including Globus Medical, RTI Surgical, Implanet, Lima Corporate and ExacTech, among others.
- Headquarter Taunton, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$33.37 M (USD)
in 7 rounds
-
Latest Funding Round
$5 M (USD), Series B
May 29, 2018
-
Investors
JPMorgan Chase
& 3 more
-
Employee Count
Not available
-
Acquired by
Corin
(Mar 08, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OMNILife Sciences
OMNILife Sciences offers a comprehensive portfolio of products and services, including ApolloKnee™, Apollo™ Robot, and BalanceBot™.
Enables personalized knee replacement planning and execution for better outcomes.
Facilitates precise bone resection in orthopaedic procedures.
Assesses knee balance pre-surgery for optimized surgical plans.
Funding Insights of OMNILife Sciences
OMNILife Sciences has successfully raised a total of $33.37M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OMNILife Sciences
OMNILife Sciences has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include JPMorgan Chase, Corin Group and Deerfield.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Financial services are provided to consumers and corporations worldwide.
|
Locked | Locked | Locked |
Investor details for OMNILife Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OMNILife Sciences
Investment portfolio details for OMNILife Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OMNILife Sciences
Detailed financials for OMNILife Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Omnilife Sciences Comparisons
Peer comparison for OMNILife Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OMNILife Sciences
OMNILife Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Globus Medical, RTI Surgical, Implanet, Lima Corporate and ExacTech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of minimally invasive products for musculoskeletal procedures
|
|
| Locked | Locked | Locked |
Develops innovative technologies for spinal and orthopedic implants and instruments.
|
|
| Locked | Locked | Locked |
Orthopedic implants are developed for spine, knee, and arthroscopy procedures.
|
|
| Locked | Locked | Locked |
Large joint primary and revision 3D printed implants for hip and knee, and fixation devices
|
|
| Locked | Locked | Locked |
Implants, instruments, and technologies for joint replacement are developed.
|
|
| Locked | Locked | Locked |
Orthopedic devices and pain management products are developed.
|
Detailed competitors of OMNILife Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Omnilife Sciences
Complete news archive for OMNILife Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OMNILife Sciences
OMNILife Sciences was founded in 1999 and raised its 1st funding round 10 years after it was founded.
OMNILife Sciences is headquartered in Taunton, United States. It is registered at Taunton, Massachusetts, United States.
OMNILife Sciences is a funded company, having raised a total of $33.37M across 7 funding rounds to date.
OMNILife Sciences was founded in 1999 in Taunton, United States, within the orthopedic devices sector. Hip and knee implants are designed, produced, and distributed, incorporating features developed with surgeon input. A proprietary robotics and navigation platform, OMNInav, is utilized, including computer-assisted cutting guide technology called OMNIplasty. Robotic-assisted solutions like OMNIBotics enable patient-specific total knee replacements.
OMNILife Sciences's top competitors include Globus Medical, ExacTech and Implanet.
OMNILife Sciences offers ApolloKnee™, Apollo™ Robot, and BalanceBot™.
OMNILife Sciences has 4 investors. Key investors include JPMorgan Chase, Corin Group, Deerfield, and Pioneer Capital.